메뉴 건너뛰기




Volumn 503, Issue 1, 2010, Pages 84-94

Liver and bone

Author keywords

Cholestasis; Cirrhosis; Liver transplantation; Metabolic bone disease; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; BILE ACID; BILIRUBIN; CALCITONIN; CALCIUM; COLECALCIFEROL; ETIDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; PLACEBO; RALOXIFENE; STRONTIUM RANELATE; TESTOSTERONE; ZOLEDRONIC ACID;

EID: 77956716170     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2010.05.030     Document Type: Review
Times cited : (65)

References (130)
  • 1
    • 0022544074 scopus 로고
    • Compston J.E. Gut 1986, 27:1073-1090.
    • (1986) Gut , vol.27 , pp. 1073-1090
    • Compston, J.E.1
  • 56
    • 34047210813 scopus 로고    scopus 로고
    • Bone disease after liver transplantation
    • Elsevier Academic Press, Amsterdam, J. Compston, E. Shane (Eds.)
    • Guanabens N., Monegal A. Bone disease after liver transplantation. Bone Disease of Organ Transplantation 2005, 271-285. Elsevier Academic Press, Amsterdam. J. Compston, E. Shane (Eds.).
    • (2005) Bone Disease of Organ Transplantation , pp. 271-285
    • Guanabens, N.1    Monegal, A.2
  • 70
    • 77956770259 scopus 로고    scopus 로고
    • High bilirubin reduces cell survival and differentiation of primary human osteoblasts. Is this effect applicable to the serum of chronic cholestatic patients? in: J. Hepatol. 52 (2010) s214-s215. Abstract
    • S. Ruiz-Gaspa, A. Martinez-Ferrer, A. Enjuanes, P. Peris, M. J. Martinez de Osaba, L. Alvarez, A. Monegal, A. Combalia, N. Guanabens, A. Pares, High bilirubin reduces cell survival and differentiation of primary human osteoblasts. Is this effect applicable to the serum of chronic cholestatic patients? in: J. Hepatol. 52 (2010) s214-s215. Abstract.
    • (2010)
    • Ruiz-Gaspa, S.1    Martinez-Ferrer, A.2    Enjuanes, A.3    Peris, P.4    Martinez de Osaba, M.J.5    Alvarez, L.6    Monegal, A.7    Combalia, A.8    Guanabens, N.9    Pares, A.10
  • 85
    • 77956725758 scopus 로고    scopus 로고
    • in: Undercarboxylation of serum osteocalcin in primary biliary cirrhosis (PBC); Reversal by vitamin K1
    • S.J. Hodges, E. Rigney, R. Eastell, A. Lee, D. Gleeson, in: Undercarboxylation of serum osteocalcin in primary biliary cirrhosis (PBC); Reversal by vitamin K1. (2000) p. 309A.
    • (2000)
    • Hodges, S.J.1    Rigney, E.2    Eastell, R.3    Lee, A.4    Gleeson, D.5
  • 95
    • 77956786468 scopus 로고    scopus 로고
    • Pathogenesis of transplantation bone disease: a unifying hypothesis
    • Elsevier Academic Press, Amsterdam, J. Compston, E. Shane (Eds.)
    • Eastell R., Naylor K.E., Cooper A.M. Pathogenesis of transplantation bone disease: a unifying hypothesis. Bone Disease of Organ Transplantation 2005, 209-220. Elsevier Academic Press, Amsterdam. J. Compston, E. Shane (Eds.).
    • (2005) Bone Disease of Organ Transplantation , pp. 209-220
    • Eastell, R.1    Naylor, K.E.2    Cooper, A.M.3
  • 99
    • 84889273461 scopus 로고    scopus 로고
    • Biochemical markers of bone turnover in osteoporosis
    • American Society of Bone and Mineral Research, Washington, C.J. Rosen (Ed.)
    • Szulc P., Delmas P.D. Biochemical markers of bone turnover in osteoporosis. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2008, 174-179. American Society of Bone and Mineral Research, Washington. C.J. Rosen (Ed.).
    • (2008) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism , pp. 174-179
    • Szulc, P.1    Delmas, P.D.2
  • 101
    • 77956783269 scopus 로고    scopus 로고
    • La presencia de ascitis infravalora la medición de la densidad mineral ósea en esqueleto axial. Implicaciones en el diaghnóstico de osteoporosisi en los pacientes con cirrosis hepática, in: Gastroenterol Hepatol
    • N. Guanabens, R. Reyes, A. Martinez-Ferrer, A. Monegal, A. Muxi, J. Caballeria, P. Peris, F. Pons, A. Pares, La presencia de ascitis infravalora la medición de la densidad mineral ósea en esqueleto axial. Implicaciones en el diaghnóstico de osteoporosisi en los pacientes con cirrosis hepática, in: Gastroenterol Hepatol (2010) p. 145.
    • Guanabens, N.1    Reyes, R.2    Martinez-Ferrer, A.3    Monegal, A.4    Muxi, A.5    Caballeria, J.6    Peris, P.7    Pons, F.8    Pares, A.9
  • 108
    • 33746689149 scopus 로고    scopus 로고
    • Alendronate 70mg once-weekly is more effective and has a better tolerability than alendronate 10mg daily in the treatment of osteopenia associated with primary biliary cirrhosis
    • Guanabens N., Vazquez I., Alvarez L., Pons F., Caballeria L., Cerda D., Peris P., Monegal A., Pares A. Alendronate 70mg once-weekly is more effective and has a better tolerability than alendronate 10mg daily in the treatment of osteopenia associated with primary biliary cirrhosis. J. Bone. Miner. Res 2005, 20:S279.
    • (2005) J. Bone. Miner. Res , vol.20
    • Guanabens, N.1    Vazquez, I.2    Alvarez, L.3    Pons, F.4    Caballeria, L.5    Cerda, D.6    Peris, P.7    Monegal, A.8    Pares, A.9
  • 109
    • 77956764767 scopus 로고    scopus 로고
    • Monthly ibandronate vs. weekly alendronate in the treatment of osteoporosis associated with primary biliary cirrhosis: similar efficacy but different adherence
    • Guanabens N., Cerda D., Monegal A., Muxi A., Caballeria L., Peris P., Pons F., Pares A. Monthly ibandronate vs. weekly alendronate in the treatment of osteoporosis associated with primary biliary cirrhosis: similar efficacy but different adherence. J. Bone Miner. Res. 2009, 1:224.
    • (2009) J. Bone Miner. Res. , vol.1 , pp. 224
    • Guanabens, N.1    Cerda, D.2    Monegal, A.3    Muxi, A.4    Caballeria, L.5    Peris, P.6    Pons, F.7    Pares, A.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.